Curis (CRIS) Assets Average (2011 - 2026)
Curis' (CRIS) quarterly Assets Average came in at $24.3 million in Q2 2026, down 29.03% on a YoY basis from $34.3 million in Q2 2025, and down 2.01% quarter-over-quarter from $24.8 million in Q1 2026.
Analysis
Curis (CRIS) Assets Average (2011 - 2026) Analysis & Trends
Curis (CRIS) has reported Assets Average for 16 consecutive years, with $24.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average fell 29.03% year-over-year to $24.3 million; the trailing twelve-month figure through Jun 2026 stood at $24.3 million (down 29.03% YoY), and the FY2025 full-year result was $30.6 million, down 48.35% from the prior year.
- Assets Average eased to $24.3 million in Q2 2026 per CRIS's latest filing, from $24.8 million in the prior quarter.
- Across five years, Assets Average topped out at $151.5 million in Q1 2022 and bottomed at $23.8 million in Q4 2025.
- Historically, Assets Average has averaged $71.1 million across 5 years, with a median of $62.9 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average retreated 23.27% in 2022, then tumbled 49.93% in 2024.
- Over 5 years, Assets Average stood at $115.9 million in 2022, then decreased by 27.81% to $83.6 million in 2023, then tumbled by 49.93% to $41.9 million in 2024, then plunged by 43.15% to $23.8 million in 2025, then gained by 2.2% to $24.3 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $24.3 million, $24.8 million, and $23.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Curis | 2.63 Mn | -2.99 Mn | - | 24.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.33 Mn |
| Mar 31, 2026 | 24.83 Mn |
| Dec 31, 2025 | 23.80 Mn |
| Sep 30, 2025 | 28.44 Mn |
| Jun 30, 2025 | 34.28 Mn |
| Mar 31, 2025 | 40.30 Mn |
| Dec 31, 2024 | 41.87 Mn |
| Sep 30, 2024 | 46.44 Mn |
| Jun 30, 2024 | 56.22 Mn |
| Mar 31, 2024 | 69.65 Mn |
| Dec 31, 2023 | 83.63 Mn |
| Sep 30, 2023 | 87.14 Mn |
| Jun 30, 2023 | 89.43 Mn |
| Mar 31, 2023 | 101.70 Mn |
| Dec 31, 2022 | 115.85 Mn |
| Sep 30, 2022 | 125.84 Mn |
| Jun 30, 2022 | 134.79 Mn |
| Mar 31, 2022 | 151.52 Mn |
| Dec 31, 2021 | 167.19 Mn |
| Sep 30, 2021 | 176.64 Mn |